# Metabolic Characteristics of Sarcoma In Vivo Using HP 13-C Magnetic Resonance Spectroscopic Imaging (MRSI)

> **NCT03759704** · — · WITHDRAWN · sponsor: **University of Texas Southwestern Medical Center**

## Conditions studied

- Sarcoma, Soft Tissue

## Interventions

- **DRUG:** Hyperpolarized 13CPyruvate

## Key facts

- **NCT ID:** NCT03759704
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-01-01
- **Primary completion:** 2021-08-26
- **Final completion:** 2021-08-26
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants meeting inclusion criteria were found.
- **Last updated:** 2022-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03759704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03759704, "Metabolic Characteristics of Sarcoma In Vivo Using HP 13-C Magnetic Resonance Spectroscopic Imaging (MRSI)". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03759704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*